Human Genome, Glaxo Lupus Drug Moves Forward

Previous Video: Charting the FTSE, Dow and Gold
Next Video: Madoff: "Amazing" He Wasn't Caught

Airtime: ET

Human Genome and GlaxoSmithKline will seek FDA approval in the first half of next year for Lupus drug Benlista. CNBC's Mike Huckman discusses the drug with Thomas Watkins, of Human Genome Sciences.

Previous Video: Charting the FTSE, Dow and Gold
Next Video: Madoff: "Amazing" He Wasn't Caught

LATEST VIDEO

Jobs Bill on the Way?

Discussing President Obama's concern over unemployment, with James Pethokoukis, Reuters Money & Politics columnist; David Goodfriend former Clinton White House staffer; Robert Reich, former Labor Secretary and Stephen Moore, The Wall Street Journal advisory board.

Reid's Health Care Hurdle
Discussing the future of President Obama's health care plan, with CNBC's Hampton Pearson and Sen. Kit Bond (R-MO).

Data is a real-time snapshot *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc. All Rights Reserved.
A Division of NBC Universal

Human Genome, Glaxo Lupus Drug Moves Forward

More Videos from CNBC

TOP VIDEO

LATEST VIDEO